Cortrophin Gel Now Widely Available in US for Acute Relapses
ANI Pharmaceuticals has announced the full U.S. commercial availability of Cortrophin Gel (repository corticotropin injection), an injectable therapy approved for managing acute relapses in people with multiple sclerosis (MS) and other autoimmune disorders. āPatients with certain chronic autoimmune conditions often need additional treatment options,ā Mary Pao Seideman, MD,…